Replies to post #20171 on Synaptogenix Inc (SNPX)

[Theburg]

Yes, I know. I take moderately severe, as severe, but moderately. The point I was making is this company is going after a population that others don’t want to tackle.That should give more value to the company if the trial is a success. A premium will be deserved.